Why the study?
The relationship between noninvasive cardiac diagnostic testing intensity and downstream clinical outcomes in patients discharged from the emergency department after assessment for chest pain was unclear.
Does evaluation in hospital networks with high noninvasive cardiac diagnostic testing intensity reduce acute myocardial infarction or all-cause mortality in patients discharged from the emergency department after assessment for chest pain?
Does evaluation in hospital networks with high noninvasive cardiac diagnostic testing intensity reduce acute myocardial infarction or all-cause mortality in patients discharged from the emergency department after assessment for chest pain?
Higher intensity of noninvasive cardiac testing after emergency department discharge for chest pain is not associated with reductions in subsequent myocardial infarction or all-cause mortality up to 1 year.
No reduction in events with higher testing intensity; leaves open whether selective noninvasive testing improves outcomes after ED chest pain evaluation.
Background The relationship between noninvasive cardiac diagnostic testing intensity and downstream clinical outcomes is unclear. Our objective was to examine the relationship between hospital network noninvasive cardiac diagnostic testing intensity and downstream clinical outcomes in patients who were discharged from the emergency department after assessment for chest pain. Methods and Results We employed a retrospective cohort study design of 387 809 patients evaluated for chest pain in the emergency department between April 1, 2010 and March 31, 2016. Hospital networks were divided into tertiles based on usage of noninvasive cardiac diagnostic testing. The primary outcome was a composite of acute myocardial infarction or all-cause mortality. Adjusted Cox proportional hazards models were used to compare the hazard of the composite outcome of myocardical infarction and/or all-cause mortality between the tertiles. After adjustment for clinically relevant covariates, patients evaluated for chest pain in intermediate noninvasive cardiac diagnostic testing usage tertile hospital networks did not have significantly different hazards of the composite outcome when compared with those evaluated in low usage tertile hospital networks >90 days (hazard ratio [HR], 1.00; 95% CI, 0.83-1.21), 6 months (HR, 1.07; 95% CI, 0.92-1.24), and 1 year (HR, 1.03; 95% CI, 0.94-1.14). Patients evaluated in the high usage tertile also did not have significantly different hazards of the composite outcome compared with those evaluated in the low usage tertile at 90 days (HR, 0.98; 95% CI, 0.80-1.19), 6 months (HR, 1.01; 95% CI, 0.87-1.17); and 1 year (HR, 0.95; 95% CI, 0.86-1.05). Conclusions Our population-based study demonstrated that high noninvasive cardiac diagnostic testing use intensity was not associated with reductions in downstream myocardial infarction or all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Roifman et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: